Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
aducanumab
advances in neurology
adverse drug reaction
algorithm
Alzheimer's disease
Alzheimer's disease, early onset
Alzheimer's disease, pathogenesis
Alzheimer's disease, treatment of
amyloid
amyloid angiopathy, cerebral
amyloid angiopathy, cerebral, inflammatory type
amyloid beta protein
amyloid beta protein antibodies
amyloid beta-related angiitis
amyloid deposition
amyloid plaques
amyloid-related imaging abnormalities
aneurysm
aneurysm, intracranial
angiitis
angiitis, granulomatous of CNS
angiitis, isolated of CNS
anti-amyloid therapy
anticoagulant, reversal of
anticoagulant, treatment
apolipoprotein E
apoliprotein E, plasma level
B 12 deficiency
Behcet's syndrome
biologic markers
blood pressure
brain biopsy
carbon monoxide poisoning
CAT scan
CAT scan, emission
CAT scan, emission, abnormal
central nervous system, infection of
central pontine myelinolysis
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebral venous thrombosis
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident, complications with
cerebrovascular disease
chemotherapy, CNS treatment and complications with
coma
complications
confusion
contraindications
controversies in neurology
cortical blindness
cost
coumarin
dementia
dementia, rapidly progressive
dementia, reversible
dementia, treatment of
demyelinating disease
disease modifying agents
dizziness
donanemab
efficacy
emergency room
emergency room, treatment of stroke
encephalitis, human immunodeficiency virus type 1
encephalitis, viral
enzyme inhibition
gadolinium
gantenerumab
Glasgow coma score
gliomatosis cerebri
granulomatous disease
headache
hearing loss
hemosiderosis of CNS, superficial
hemosiderosis, subarachnoid
human immunodeficiency virus type 1
hypertension
hypertensive encephalopathy
iatrogenic neurologic disorders
immunomodulation
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, pathophysiology
intracerebral hemorrhage, small
intracranial pressure, increased
intracranial pressure, increased, treatment of
lecanemab
leukoencephalopathy
leukoencephalopathy, differential diagnosis
limbic encephalitis
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
meningeal biopsy
meningeal enhancement
mental status, abnormal
microhemorrhage, intracerebral
migraine
mild cognitive impairment
misdiagnosis
mitochondrial disease
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, mass effect on
multiple sclerosis
myoclonus
negative
neoplasm, primary of CNS
neurologic examination, focal
neuropathology
phenylketonuria
Pittsburgh Compound B
platelet inhibiting drugs
pleocytosis of cerebrospinal fluid
posterior leukoencephalopathy syndrome
prevention of neurologic disorders
prognosis
progressive multifocal leucoencephalopathy
radiation therapy, CNS treatment and complications with
recombinant activated factor VII
remternetug
reversible neurologic disorder
review article
risk factors
safety
sarcoidosis
sarcoidosis, CNS
seizure
shared decision making
symmetric brain lesions
temporal lobe
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
transient neurologic deficit
treatment of neurologic disorder
vasculitides
vasculopathy
Whipple's disease
white matter disease
Showing articles 250 to 300 of 11417 << Previous Next >>

Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, HHV6 Encephalitis in Stem Cell Transplant
Adams & Victors Principles of Neurology, Chp 33, pg 753, Ropper, A.H.,et al, 2014

Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Sarcoidosis
Adams & Victors Principles of Neurology, Chp 32, pg 721, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Alzheimer Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1063, Ropper, A.H.,et al, 2014

Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014

Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013

Febrile Infection-Related Epilepsy Syndrome: A Study of 12 Patients
Seizure 22:553-559, Caraballo, R.H.,et al, 2013

The Spectrum of Statin Myopathy
Curr Opin Rheumatol 25:747-752, Mohassel, P. & Mammen, A.L., 2013

Tumor Necrosis Factor-Alpha Inhibitors: An Overview of Adverse Effects
UpToDate January, Stone, J.H., 2013

Tumor Necrosis Factor-Alpha Inhibitors: Risk of Malignancy
UpToDate January, Stone, J.H., 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013

Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013

Human Herpes 6 Virus Encephalitis Complicating Allogeneic Hematopoietic Stem Cell Transplantation
Neurol 80:1494-1500, Bhanushali, M.,et al, 2013

Autoimmune Limbic Encephalopathy and Anti-Hu Antibodies in Children without Cancer
Neurol 80:2226-2232, Honnorat, J.,et al, 2013

Paediatric Autoimmune Encephalopathies: Clinical Features, Laboratory Investigations and Outcomes in Patients with or without Antibodies to known Central Nervous System Autoantigens
JNNP 84:748-755, Hacohen, Y.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Late-Onset Anti-NMDA Receptor Encephalitis
Neurol 81:1058-1063, Titulaer, M.,et al, 2013

Frequency and Characteristics of Isolated Psychiatric Episodes in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
JAMA Neurol 70:1133-1139, Kayser, M.S.,et al, 2013

Overlooked non-motor Symptoms in Myasthenia Gravis
JNNP 84:989-994, Suzuki, S.,et al, 2013

Sarcoidosis Presenting as Longitudinally Extensive Myelitis
Neurol 81:e61, Goenka, N. & Venna N., 2013

Encephalitis and GABAb Receptor Antibodies
Neurol 81:1500-1506, H�ftberger, R.,et al, 2013

Long-lasting Treatment Effect of Rituximab in MuSK Myasthenia
Neurol 78:189-193, Diaz-Manera,J.,et al, 2012

Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012

Memantine for Dementia in Adults Older than 40 years with Downs Syndrome (MEADOWS): a Randomised,double-blind,placebo-controlled Trial
Lancet 379:528-536, Hanney,M.,et al, 2012

Stiff-Man Syndrome and Variants
Arch Neurol 69:230-238, McKeon,A.,et al, 2012

Cerebral Amyloid Angiopathy
eMedicine, Jan, Menon, R.S., 2012

Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012

Fatal PML Associated with Efalizumab Therapy
Neurol 78:458-467, Schwab,N.,et al, 2012

Inflammatory Myopathies with Anti-Ku Antibodies
Medicine 91:95-102, Rigolet,A.,et al, 2012

Evidence-based Guideline Update: NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults
Neurol 78:1346-1353, Holland,S.,et al, 2012

Autoimmune Epilepsy
Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012

Central Nervous System Neuronal Surface Antibody Associated Syndromes: Review and Guidelines for Recognition
JNNP 83:638-645, Zuliani,L.,et al, 2012

Treatment of Behcets Disease
UpToDate, Jan, Smith, E.L. & Yazici, Y., 2012

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

Hashimoto Encephalopathy
Neurol 78:e134, Afshari, M.,et al, 2012

Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012

Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas are Associated with Improved Survival Compared with Matched Controls
AJNR 33:1763-1770, Mong, S.,et al, 2012

Fatal Varicella-Zoster Virus Vasculopathy Associated with Adalimumab Therapy
Arch Neurol 69:1193-1196, Baek, W.,et al, 2012

Myasthenia Gravis
BMJ 345:e8497, Spillane, J.,et al, 2012

PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012

Treatment of ?-Aminobutyric Acid� Receptor-Antibody Autoimmune Encephalitis with Oral Corticosteroids
Arch Neurol 69:1061-1063, Goldenholz, D.M.,et al, 2012

Morvan Syndrome: Clinical and Serological Observations in 29 Cases
Ann Neurol 72:241-255, Irani, S.R.,et al, 2012

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

A Trial of Intracranial-Pressure Monitoring in Traumatic Brain Injury
NEJM 367:2471-2481,2539, Chesnut, R.,et al, 2012

Immunotherapy-Responsive Chorea as the Presenting Feature of LGI1-Antibody Encephalitis
Neurol 79:195-196, Tofaris,G.K.,et al, 2012

Hyperosmolar Therapy for Raised Intracranial Pressure
NEJM 367:746-752, Ropper, A.H., 2012

Adult Primary Central Nervous System Vasculitis
Lancet 380:767-777, Salvarani, C.,et al, 2012

Clinicopathologic Conference, Paraneoplastic Stiff Person Syndrome with Limbic Encephalitis with Anti-Amphiphysin Antibodies with Metastatic Carcinoma of Breast
NEJM 367:851-861, Case 27-2012, 2012

Lifelong Management of Amyloid-Beta Metabolism to Prevent Alzheimers Disease
NEJM 367:864-866, Gandy, S., 2012

The Diagnosis and Treatment of Limbic Encephalitis
Acta Neurol Scand 126:365-375, Asztely, F. & Kumliem, E., 2012

Herpes Encephalitis During Natalizumab Tretament in Multiple Sclerosis
Mult Scler J 18:909-911, Kwiatkowski, A.,et al, 2012



Showing articles 250 to 300 of 11417 << Previous Next >>